Skip to main content
. 2021 Jul 20;2021(7):CD013196. doi: 10.1002/14651858.CD013196.pub2

NCT00752531.

Methods Study design: single‐blinded, parallel individual randomised controlled trial
Duration: 78 weeks
Setting: unknown
Participants Population: 280 adult participants to be recruited in the United States
Baseline characteristics: unknown
Inclusion criteria: ≥ 21 years, understands English, has working telephone/cable, with diagnosed COPD, stage II/III COPD
Exclusion criteria: moving from study area before study complete, health condition causing participant to not carry out study expectations, not able to use telephone and without assistance to do so
Interventions Measurements at baseline and at 3, 6, 9, 12, 15, and 18 months
Treatment arms
  1. Computer device for data telecommunication sessions

  2. Personalised self‐care plan and education

  3. Patients assessed 7 times ‐ 4 at research site and 3 at home every 3 months

Outcomes Primary outcomes: lung function, respiratory symptoms
Secondary outcomes: quality of life, use of health care, activities of daily living, self‐efficacy, exercise tolerance
Notes Funding: John Hopkins University
Other identifier:NCT00752531